Ohshima Tomoko, Mukai Yoko, Watanabe Hitoshi, Ohshima Keijiro, Makimura Koichi, Komabayashi Takashi, Ahn Chul, Meyer Karen, Maeda Nobuko
Department of Oral Microbiology, School of Dental Medicine, Tsurumi University, 2-1-3 Tsurumi, Tsurumi-ku, Yokohama 230-8501, Japan.
Institute of Medical Mycology, Teikyo University, 359 Otsuka, Hachioji 192-0395, Japan.
Microorganisms. 2024 Mar 5;12(3):525. doi: 10.3390/microorganisms12030525.
was reclassified from the genotype D, and reports show its frequent detection in HIV-positive individuals and easy acquisition of antifungal drug resistance. However, the oral carriage rate in healthy people and contribution to candidiasis in Japan is unclear.
We conducted a cross-sectional survey of the carriage rate, performed genotyping and tested antifungal drug susceptibility and protease productivity. Specimens from 2432 Japanese subjects in six regions (1902 healthy individuals, 423 with candidiasis individuals, 107 HIV-positive individuals) were cultured using CHROMagarCandida, and the species was confirmed via 25S rDNA amplification and ITS sequences analyzed for genotyping.
The carriage rate in healthy Japanese was low in the central mainland (0-15%) but high in the most northerly and southerly areas (30-40%). The distribution of these frequencies did not differ depending on age or disease (HIV-infection, candidiasis). Genotype I, previously identified in other countries, was most frequent in Japan, but novel genotypes were also observed. Six antifungal drugs showed higher susceptibility against , but protease productivity was low.
Oral has low pathogenicity with distribution properties attributed to geography and not dependent on age or disease status.
已从基因型D重新分类,报告显示其在HIV阳性个体中频繁检出且易获得抗真菌药物耐药性。然而,在日本健康人群中的口腔携带率及其对念珠菌病的影响尚不清楚。
我们对携带率进行了横断面调查,进行基因分型并测试抗真菌药物敏感性和蛋白酶生产力。使用CHROMagar念珠菌培养基对来自六个地区的2432名日本受试者(1902名健康个体、423名念珠菌病患者、107名HIV阳性个体)的样本进行培养,并通过25S rDNA扩增确认菌种,分析ITS序列进行基因分型。
日本健康人群中的携带率在中部大陆较低(0 - 15%),但在最北部和最南部地区较高(30 - 40%)。这些频率的分布不因年龄或疾病(HIV感染、念珠菌病)而有所不同。先前在其他国家鉴定出的基因型I在日本最为常见,但也观察到了新的基因型。六种抗真菌药物对显示出较高的敏感性,但蛋白酶生产力较低。
口腔致病性较低,其分布特性归因于地理位置,而非取决于年龄或疾病状态。